217 related articles for article (PubMed ID: 23339845)
1. Lymphotoxin network pathways shape the tumor microenvironment.
Bjordahl RL; Steidl C; Gascoyne RD; Ware CF
Curr Opin Immunol; 2013 Apr; 25(2):222-9. PubMed ID: 23339845
[TBL] [Abstract][Full Text] [Related]
2. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease.
Gommerman JL; Browning JL
Nat Rev Immunol; 2003 Aug; 3(8):642-55. PubMed ID: 12974479
[TBL] [Abstract][Full Text] [Related]
3. Network communications: lymphotoxins, LIGHT, and TNF.
Ware CF
Annu Rev Immunol; 2005; 23():787-819. PubMed ID: 15771586
[TBL] [Abstract][Full Text] [Related]
4. Lymphotoxin in physiology of lymphoid tissues - Implication for antiviral defense.
Koroleva EP; Fu YX; Tumanov AV
Cytokine; 2018 Jan; 101():39-47. PubMed ID: 27623349
[TBL] [Abstract][Full Text] [Related]
5. Lymphotoxin and LIGHT signaling pathways and target genes.
Schneider K; Potter KG; Ware CF
Immunol Rev; 2004 Dec; 202():49-66. PubMed ID: 15546385
[TBL] [Abstract][Full Text] [Related]
6. Cooperative function of CCR7 and lymphotoxin in the formation of a lymphoma-permissive niche within murine secondary lymphoid organs.
Rehm A; Mensen A; Schradi K; Gerlach K; Wittstock S; Winter S; Büchner G; Dörken B; Lipp M; Höpken UE
Blood; 2011 Jul; 118(4):1020-33. PubMed ID: 21586747
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor, lymphotoxin and cancer.
Drutskaya MS; Efimov GA; Kruglov AA; Kuprash DV; Nedospasov SA
IUBMB Life; 2010 Apr; 62(4):283-9. PubMed ID: 20155809
[TBL] [Abstract][Full Text] [Related]
8. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors.
Browning JL; Dougas I; Ngam-ek A; Bourdon PR; Ehrenfels BN; Miatkowski K; Zafari M; Yampaglia AM; Lawton P; Meier W
J Immunol; 1995 Jan; 154(1):33-46. PubMed ID: 7995952
[TBL] [Abstract][Full Text] [Related]
9. Biology and signal transduction pathways of the Lymphotoxin-αβ/LTβR system.
Remouchamps C; Boutaffala L; Ganeff C; Dejardin E
Cytokine Growth Factor Rev; 2011; 22(5-6):301-10. PubMed ID: 22152226
[TBL] [Abstract][Full Text] [Related]
10. Homeostatic chemokines guide lymphoma cells to tumor growth-promoting niches within secondary lymphoid organs.
Höpken UE; Rehm A
J Mol Med (Berl); 2012 Nov; 90(11):1237-45. PubMed ID: 22577036
[TBL] [Abstract][Full Text] [Related]
11. Detection of lymphotoxins in vivo. I. Specific identification of short-lived LT activity in the plasma of various human patients employing rabbit anti-human LT sera in vitro.
Granger GA; Shimizu I; Harris L; Andreson J; Horn P
Clin Immunol Immunopathol; 1978 May; 10(1):104-15. PubMed ID: 350462
[No Abstract] [Full Text] [Related]
12. Preparation and characterization of soluble recombinant heterotrimeric complexes of human lymphotoxins alpha and beta.
Browning JL; Miatkowski K; Griffiths DA; Bourdon PR; Hession C; Ambrose CM; Meier W
J Biol Chem; 1996 Apr; 271(15):8618-26. PubMed ID: 8621492
[TBL] [Abstract][Full Text] [Related]
13. Effects of tumor necrosis factor and lymphotoxin on peripheral lymphoid tissue development.
Ettinger R; Mebius R; Browning JL; Michie SA; van Tuijl S; Kraal G; van Ewijk W; McDevitt HO
Int Immunol; 1998 Jun; 10(6):727-41. PubMed ID: 9678753
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment.
Weinstein AM; Storkus WJ
Adv Cancer Res; 2015; 128():197-233. PubMed ID: 26216634
[TBL] [Abstract][Full Text] [Related]
15. Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs.
Wilhelm P; Riminton DS; Ritter U; Lemckert FA; Scheidig C; Hoek R; Sedgwick JD; Körner H
Eur J Immunol; 2002 Jul; 32(7):1993-2003. PubMed ID: 12115620
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice.
Koni PA; Sacca R; Lawton P; Browning JL; Ruddle NH; Flavell RA
Immunity; 1997 Apr; 6(4):491-500. PubMed ID: 9133428
[TBL] [Abstract][Full Text] [Related]
17. Macrophages in tumor microenvironments and the progression of tumors.
Hao NB; Lü MH; Fan YH; Cao YL; Zhang ZR; Yang SM
Clin Dev Immunol; 2012; 2012():948098. PubMed ID: 22778768
[TBL] [Abstract][Full Text] [Related]
18. Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting.
Tumanov AV; Grivennikov SI; Shakhov AN; Rybtsov SA; Koroleva EP; Takeda J; Nedospasov SA; Kuprash DV
Immunol Rev; 2003 Oct; 195():106-16. PubMed ID: 12969314
[TBL] [Abstract][Full Text] [Related]
19. Regulation of lymphotoxin-beta by tumor necrosis factor, phorbol myristate acetate, and ionomycin in Jurkat T cells.
Voon DC; Subrata LS; Abraham LJ
J Interferon Cytokine Res; 2001 Nov; 21(11):921-30. PubMed ID: 11747624
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to lymphotoxin alpha (LT alpha) and LT beta recognize different glial cell types in the central nervous system.
Cannella B; Sizing ID; Benjamin CD; Browning JL; Raine CS
J Neuroimmunol; 1997 Sep; 78(1-2):172-9. PubMed ID: 9307242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
